PAR 4.08% 25.5¢ paradigm biopharmaceuticals limited..

Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-5

  1. 954 Posts.
    lightbulb Created with Sketch. 286
    Take forecasts with a grain of salt. Company has proven they can’t manage $. If they’re forecasting 8 to 11 in outflow next quarter it’s likely they’ll be at $0 in the account.

    Absolutely dreaming if they think options come into play. If I was a partner I would NOT be partnering for the next two quarters minimum.
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.